Shah Zeb
University: Washington University of Science and Technology, 2900 Eisenhower Ave, Alexandria, VA

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

AI in Healthcare: Revolutionizing Diagnosis and Therapy Shah Zeb; Nizamullah FNU; Nasrullah Abbasi; Muhammad Fahad
International Journal of Multidisciplinary Sciences and Arts Vol. 3 No. 3 (2024): International Journal of Multidisciplinary Sciences and Arts, Article July 2024
Publisher : Information Technology and Science (ITScience)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47709/ijmdsa.v3i3.4546

Abstract

Artificial Intelligence (AI) is revolutionizing healthcare through its integration into various domains, significantly enhancing the efficiency, accuracy, and effectiveness of medical practices. This review explores the transformative impact of AI across multiple aspects of healthcare, including diagnostics, personalized treatment, drug discovery, surgery, and more. AI's capabilities in diagnostics and early detection are improving the precision and speed of disease identification, enabling earlier and more effective interventions. Personalized treatment approaches leverage AI to analyze patient data and tailor therapies to individual needs, optimizing outcomes and reducing adverse effects. AI-driven robotics in surgery offer enhanced precision, control, and minimally invasive options, leading to improved surgical outcomes and faster recovery times. Despite these advancements, the adoption of AI in healthcare presents challenges and ethical considerations, including data quality, algorithmic bias, patient privacy, and the responsible use of AI technologies. Addressing these issues is crucial for maintaining trust and ensuring equitable access to AI-powered healthcare solutions. AI's role in drug discovery and development is accelerating the creation of new therapies by optimizing predictive modeling, drug design, and clinical trials, thus reducing costs and speeding up the development process. Future trends and innovations in AI highlight ongoing advancements and the potential for further transformation in healthcare. These include advancements in natural language processing, AI-enhanced telemedicine, wearable health technologies, and ethical AI governance. As AI technology continues to evolve, its impact on healthcare will become increasingly significant, driving progress in patient care, operational efficiency, and medical research. Collaborative efforts among technologists, clinicians, researchers, and policymakers will be essential in harnessing AI's full potential while addressing the complexities and ethical challenges associated with its use. This review underscores the promise of AI to revolutionize healthcare and improve patient outcomes while emphasizing the need for responsible implementation and ongoing evaluation.
AI IN HEALTHCARE: USING CUTTING-EDGE TECHNOLOGIES TO REVOLUTIONIZE VACCINE DEVELOPMENT AND DISTRIBUTION Nasrullah Abbasi; Nizamullah FNU; Shah Zeb
JURIHUM : Jurnal Inovasi dan Humaniora Vol. 1 No. 1 (2023): JURIHUM : Jurnal Inovasi dan Humaniora
Publisher : CV. Shofanah Media Berkah

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The field of vaccine development is being revolutionized by artificial intelligence (AI), which is bringing revolutionary advancements to every stage of the process from discovery to dissemination. This review focuses on a few important aspects as it examines how AI technology improve vaccine development procedures. By locating antigen targets, forecasting immune responses, and refining vaccine designs via sophisticated machine learning and computational biology, artificial intelligence (AI) expedites the search for new vaccines. Artificial Intelligence (AI) enhances clinical trial efficacy by facilitating real-time data monitoring, optimizing trial designs, and improving participant recruitment. AI improves quality control, predictive maintenance, and process efficiency in the production of vaccines, resulting in constant and dependable output. AI also facilitates timely and equitable vaccination delivery by optimizing cold chain management, transportation logistics, and supply chain management. Despite these developments, there are still issues with data integration and quality, model transparency, ethical and legal issues, and computational resource requirements when using AI in vaccine development. Prospective avenues for investigation comprise investigating tailored vaccinations, improving real-time monitoring, and advocating for worldwide health parity. Leveraging AI's full potential to advance vaccine research will require addressing these issues and seeking creative solutions. Improvements in health outcomes and more efficient responses to risks to global health will result from the ongoing cooperation of AI specialists, vaccine developers, and public health agencies.